Placebo Controlled Study of Repetitive Transcranial Magnetic Stimulation for the Treatment of Parkinson's Disease
Abstract
During the period of the study we researched the effects of 25 Hz rTMS in 12 patients with PD. Eight rTMS sessions were performed over a four-week period. Four cortical targets were stimulated in each of the sessions (left and right motor and dorsolateral prefrontal cortex) with 300 pulses each. We haven't done any type of the interim statistical analysis of the results at this point and will not do so until enough data has been collected. Preliminary results indicate the cumulative reduction of bradykinesia in the course of rTMS sessions. This manifested itself by a decrease of the time needed to execute motor tests. rTMS used under the parameters of the regimen is safe in patients with PD.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jul 01, 2003
- Accession Number
- ADA421927
Entities
People
- Mark Hallett
Organizations
- National Institutes of Health